文献速递血栓与止血

载有脂质体包裹凝血酶的血小板凝血能力增强

Platelets loaded with liposome-encapsulated thrombin have increased coagulability.
PubMed 文献 · J Thromb Haemost · 2018-04-20

该研究将凝血酶包裹于纳米脂质体并在体外递送至血小板,通过多种体外实验检测血小板活化、血块收缩、凝血时间和血块稳定性,发现载脂质体凝血酶的血小板对激动剂更敏感、反应性增强,并在酸中毒、抗血小板药物、A型血友病和创伤诱导性凝血病等凝血受损条件下改善凝血时间。

要点

  • 脂质体凝血酶被血小板内吞并在体外被利用,但活化后不被分泌。
  • 载脂质体凝血酶的血小板对激动剂更敏感、反应性增强。
  • 在酸中毒、抗血小板药物、A型血友病和创伤诱导性凝血病条件下凝血时间改善。

核心结论

  • 体外递送脂质体凝血酶增强了血小板功能的多个方面。
  • 载脂质体凝血酶的血小板可在体外克服某些凝血病性缺陷。

研究设计与样本

  • 体外研究:将凝血酶包裹于纳米脂质体并在体外递送至血小板,通过多种体外实验检测血小板活化、血块收缩、凝血时间和血块稳定性。

主要发现

  • 脂质体凝血酶被血小板内吞并在体外被利用,但活化后不被分泌。
  • 载脂质体凝血酶的血小板对激动剂更敏感、反应性增强。
  • 在酸中毒、抗血小板药物、A型血友病和创伤诱导性凝血病条件下凝血时间改善。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials Platelet transfusions can have limited efficacy during hemorrhage associated with coagulopathy. Thrombin can be shielded by encapsulation into nanoliposomes and delivered to platelets ex vivo. Loading platelets with liposomal thrombin improved several aspects of platelet coagulability. Platelets loaded with liposomal thrombin can overcome some coagulopathic deficiencies in vitro. SUMMARY: Background Platelets are integral to clot formation and are often transfused to stop or prevent bleeding. However, transfusions of platelets are not always effective, particularly in the most severe cases of hemorrhage. Nanoparticle systems have been developed to mimic platelets but inherently lack important aspects of platelet function, which limits their potential effectiveness. Objectives Increasing the natural coagulability of transfusable platelets could increase their efficacy during treatment of severe hemorrhage. Thrombin is a potent platelet agonist that currently cannot be used intravenously because of the risk of thrombosis. We hypothesized that delivery of thrombin to ex vivo platelets via liposomal encapsulation would enable transfusable platelets to become more coagulable in response to platelet agonists. Methods Thrombin was encapsulated into nanoliposomes and delivered to platelets ex vivo. Platelet coagulability was measured by monitoring platelet activation, clot contraction, clot time and clot stability in several in vitro assays. These parameters were also measured under conditions where coagulation is compromised, including during acidosis, antiplatelet drugs, hemophilia A and trauma-induced coagulopathy. Results Liposomal thrombin was endocytosed and used by platelets ex vivo but was not secreted upon activation. These modified platelets became more sensitive and responsive to agonists and improved clotting time even under conditions that normally cause platelet dysfunction or have impaired coagulation. Conclusions Several aspects of platelet function were enhanced by ex vivo delivery of liposomal thrombin.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Chan V, Sarkari M, Sunderland R, et al. Platelets loaded with liposome-encapsulated thrombin have increased coagulability. J Thromb Haemost. 2018. PMID: 29573326. doi:10.1111/jth.14006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。